Ryan G. Keddy
AbbVie (United States)(US)
Publications by Year
Research Areas
Ion Channels and Receptors, Pain Mechanisms and Treatments, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Herbal Medicine Research Studies
Most-Cited Works
- → Cyclopentannulation of 3-Alkylindoles: A Synthesis of a Tetracyclic Subunit of the Kopsane Alkaloids(2001)150 cited
- → Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A(2014)126 cited
- → The annulation of 3-alkylindoles with 1,1-cyclopropanediesters(1999)92 cited
- → Highlights of the Structure–Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530)(2018)53 cited
- → Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists(2008)48 cited
- → α-Methylation at benzylic fragment of N-aryl-N′-benzyl ureas provides TRPV1 antagonists with better pharmacokinetic properties and higher efficacy in inflammatory pain model(2007)32 cited
- → In Vitro Structure−Activity Relationship and In Vivo Characterization of 1-(Aryl)-3-(4-(amino)benzyl)urea Transient Receptor Potential Vanilloid 1 Antagonists(2007)26 cited
- → Discovery of TRPV1 antagonist ABT-116(2010)21 cited
- → Real-Time Atom Residence Time Compensation in Chemical Vapor Generation Atomic Spectrometry. A More Precise Analytical Signal(1998)2 cited
- → ChemInform Abstract: The Annulation of 3‐Alkylindoles with 1,1‐Cyclopropanediesters.(1999)